Developing cutting-edge exosome-based solutions to tackle cancer and advance the future of immuno-oncology.
Harnessing engineered biology and AI to turn food waste into clean, on-site energy.
AI-designed genetic sequencing to dramatically increase production yields of biologics.
A biomarker discovery company using AI to impute epigenetic markers of neurodegenerative diseases from blood.
Delivering safer, simpler, faster mRNA therapies for rare and complex disease, enabled by AI.
Transforming the treatment of gut disorders, starting with IBS, by leveraging multi-omics AI and proprietary nuclease-based technology.
Revolutionising respiratory medicine through novel aerosol technologies to improve inhaled and nasal drug delivery.
Get the latest news, updates, tools, and information from Zinc straight to your inbox with Zinc’s monthly newsletter.